Skip to main content Accessibility help
×
Home

Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial

  • Louise F. Clark (a1) (a2), M. C. Thivierge (a1), Claire A. Kidd (a1), Susan C. McGeoch (a2), Prakash Abraham (a2), Donald W. M. Pearson (a2), Graham W. Horgan (a3), Grietje Holtrop (a3), Frank Thies (a1) and Gerald E. Lobley (a1)...

Abstract

The effects of fish oil (FO) supplementation on glycaemic control are unclear, and positive effects may occur only when the phospholipid content of tissue membranes exceeds 14 % as n-3 PUFA. Subjects (n 36, thirty-three completed) were paired based on metabolic parameters and allocated into a parallel double-blind randomised trial with one of each pair offered daily either 6 g of FO (3·9 g n-3 PUFA) or 6 g of maize oil (MO) for 9 months. Hyperinsulinaemic–euglycaemic–euaminoacidaemic (HIEGEAA) clamps (with [6,6 2H2 glucose]) were performed at the start and end of the intervention. Endogenous glucose production (EGP) and whole-body protein turnover (WBPT) were each measured after an overnight fast. The primary outcome involved the effect of oil type on insulin sensitivity related to glycaemic control. The secondary outcome involved the effect of oil type on WBPT. Subjects on FO (n 16) had increased erythrocyte n-3 PUFA concentrations >14 %, whereas subjects on MO (n 17) had unaltered n-3 PUFA concentrations at 9 %. Type of oil had no effect on fasting EGP, insulin sensitivity or total glucose disposal during the HIEGEAA clamp. In contrast, under insulin-stimulated conditions, total protein disposal (P=0·007) and endogenous WBPT (P=0·001) were both increased with FO. In an associated pilot study (n 4, three completed), although n-3 PUFA in erythrocyte membranes increased to >14 % with the FO supplement, the enrichment in muscle membranes remained lower (8 %; P<0·001). In conclusion, long-term supplementation with FO, at amounts near the safety limits set by regulatory authorities in Europe and the USA, did not alter glycaemic control but did have an impact on WBPT.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: Dr G. E. Lobley, fax +44 1224 438 699, email g.lobley@abdn.ac.uk

References

Hide All
1. American Diabetes Association (2014) National Diabetes Statistics Report, 2014. Alexandria, VA: ADA.
2. Defronzo, RA & Tripathy, D (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32, Suppl 2, S157S163.
3. Helmrich, SP, Ragland, DR, Leung, RW, et al. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325, 147152.
4. Ramel, A, Martinez, A, Kiely, M, et al. (2008) Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 51, 12611268.
5. Krebs, JD, Browning, LM, McLean, NK, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 15351544.
6. Bergeron, K, Julien, P, Davis, TA, et al. (2007) Long-chain n-3 fatty acids enhance neonatal insulin-regulated protein metabolism in piglets by differentially altering muscle lipid composition. J Lipid Res 48, 23962410.
7. Zhu, FS, Liu, S, Chen, XM, et al. (2008) Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 14, 63956400.
8. Mouratoff, GJ, Carroll, NV & Scott, EM (1967) Diabetes mellitus in Eskimos. JAMA 199, 107112.
9. Mouratoff, GJ & Scott, EM (1973) Diabetes mellitus in Eskimos after a decade. JAMA 226, 13451346.
10. Murphy, NJ, Schraer, CD, Thiele, MC, et al. (1995) Dietary change and obesity associated with glucose intolerance in Alaska Natives. J Am Diet Assoc 95, 676682.
11. Storlien, LH, Kraegen, EW, Chisholm, DJ, et al. (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237, 885888.
12. Popp-Snijders, C, Schouten, JA, Heine, RJ, et al. (1987) Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 4, 141147.
13. Fasching, P, Ratheiser, K, Waldhausl, W, et al. (1991) Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40, 583589.
14. Browning, LM, Krebs, JD, Moore, CS, et al. (2007) The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 7080.
15. Rasic-Milutinovic, Z, Perunicic, G, Pljesa, S, et al. (2007) Effects of n-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 29, 321329.
16. Glauber, H, Wallace, P, Griver, K, et al. (1988) Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108, 663668.
17. Schectman, G, Kaul, S & Kissebah, AH (1988) Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 37, 15671573.
18. Vessby, B & Boberg, M (1990) Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med 228, 165171.
19. Zambon, S, Friday, KE, Childs, MT, et al. (1992) Effect of glyburide and omega 3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 56, 447454.
20. Mostad, IL, Bjerve, KS, Bjorgaas, MR, et al. (2006) Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 84, 540550.
21. Giacco, R, Cuomo, V, Vessby, B, et al. (2007) Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis 17, 572580.
22. Vessby, B, Uusitupa, M, Hermansen, K, et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44, 312319.
23. Skulas-Ray, AC, Kris-Etherton, PM, Harris, WS, et al. (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93, 243252.
24. Sirtori, CR, Paoletti, R, Mancini, M, et al. (1997) n-3 Fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter study. Am J Clin Nutr 65, 18741881.
25. Griffin, MD, Sanders, TA, Davies, IG, et al. (2006) Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 84, 12901298.
26. Kabir, M, Skurnik, G, Naour, N, et al. (2007) Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86, 16701679.
27. Luo, J, Rizkalla, SW, Vidal, H, et al. (1998) Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 21, 717724.
28. McManus, RM, Jumpson, J, Finegood, DT, et al. (1996) A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 19, 463467.
29. Woodman, RJ, Mori, TA, Burke, V, et al. (2002) Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 76, 10071015.
30. Puhakainen, I, Ahola, I & Yki-Jarvinen, H (1995) Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 61, 121126.
31. Pelikanova, T, Kohout, M, Valek, J, et al. (1993) Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients. Ann N Y Acad Sci 683, 272278.
32. Stacpoole, PW, Alig, J, Ammon, L, et al. (1989) Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia. Metabolism 38, 946956.
33. Connor, WE, Prince, MJ, Ullmann, D, et al. (1993) The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann N Y Acad Sci 683, 337340.
34. Annuzzi, G, Rivellese, A, Capaldo, B, et al. (1991) A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 87, 6573.
35. Boberg, M, Pollare, T, Siegbahn, A, et al. (1992) Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 22, 645650.
36. Borkman, M, Chisholm, DJ, Furler, SM, et al. (1989) Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38, 13141319.
37. Smith, GI, Atherton, P, Reeds, DN, et al. (2011) Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 93, 402412.
38. Akinkuolie, AO, Ngwa, JS, Meigs, JB, et al. (2011) Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr 30, 702707.
39. Gingras, AA, White, PJ, Chouinard, PY, et al. (2007) Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signaling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol 579, 269284.
40. Fortin, M, Julien, P, Couture, Y, et al. (2010) Regulation of glucose and protein metabolism in growing steers by long-chain n-3 fatty acids in muscle membrane phospholipids is dose-dependent. Animal 4, 89101.
41. Flock, MR, Harris, WS & Kris-Etherton, PM (2013) Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev 71, 692707.
42. Smith, GI, Atherton, P, Reeds, DN, et al. (2011) Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. Clin Sci (Lond) 121, 267278.
43. Food and Nutrition Board (2005) Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academies Press.
44. EFSA Panel on Dietetic Products Nutrition and Allergies (NDA) (2012) Scientific Opinion related to the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J 10, 2815.
45. Johnstone, AM, Horgan, GW, Murison, SD, et al. (2008) Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum . Am J Clin Nutr 87, 4455.
46. Beckett, PR, Hardin, DS, Davis, TA, et al. (1996) Spectrophometric assay for measuring branched-chain amino acid concentrations: application for measuring the sensitivity of protein metabolism to insulin. Anal Biochem 240, 4853.
47. Defronzo, RA, Tobin, JD & Andres, R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237, E214E223.
48. Henriksson, KG (1979) “Semi-open” muscle biopsy technique. A simple outpatient procedure. Acta Neurol Scand 59, 317323.
49. Bligh, EG & Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911917.
50. Lobley, GE, Holtrop, G, Bremner, DM, et al. (2013) Impact of short term consumption of diets high in either non-starch polysaccharides or resistant starch in comparison with moderate weight loss on indices of insulin sensitivity in subjects with metabolic syndrome. Nutrients 5, 21442172.
51. Calder, AG & Smith, A (1988) Stable isotope ratio analysis of leucine and ketoisocaproic acid in blood plasma by gas chromatography/mass spectrometry. Use of tertiary butyldimethylsilyl derivatives. Rapid Commum Mass Spectrom 2, 1416.
52. Finegood, DT, Bergman, RN & Vranic, M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36, 914924.
53. Barazzoni, R, Kiwanuka, E, Zanetti, M, et al. (2003) Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes. Diabetes 52, 18511856.
54. Steele, R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82, 420430.
55. Matthews, DE, Schwarz, HP, Yang, RD, et al. (1982) Relationship of plasma leucine and alpha-ketoisocaproate during a l-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31, 11051112.
56. Diabetes Trial Unit (2014) The Oxford Centre for Diabetes, Endocrinology and Metabolism. www.dtu.ox.ac.uk/homacalculator/index.php (accessed September 2014).
57. Bersamin, A, Luick, BR, King, IB, et al. (2008) Westernizing diets influence fat intake, red blood cell fatty acid composition, and health in remote Alaskan Native communities in the Center for Alaska Native Health Study. J Am Diet Assoc 108, 266273.
58. Mann, NJ, O’Connell, SL, Baldwin, KM, et al. (2010) Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids 45, 669681.
59. Kamolrat, T, Gray, SR & Thivierge, MC (2013) Fish oil positively regulates anabolic signalling alongside an increase in whole-body gluconeogenesis in ageing skeletal muscle. Eur J Nutr 52, 647657.
60. Storlien, LH, Jenkins, AB, Chisholm, DJ, et al. (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40, 280289.
61. Harris, WS & Schmitt, TL (2014) Unexpected similarity in RBC DHA and AA levels between bottlenose dolphins and humans. Prostaglandins Leukot Essent Fatty Acids 90, 5559.
62. Muller, S, Martin, S, Koenig, W, et al. (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45, 805812.
63. Herder, C, Baumert, J, Thorand, B, et al. (2006) Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002. Diabetologia 49, 921929.
64. Todoric, J, Loffler, M, Huber, J, et al. (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49, 21092119.
65. Farzaneh-Far, R, Harris, WS, Garg, S, et al. (2009) Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul study. Atherosclerosis 205, 538543.
66. Mahendran, Y, Agren, J, Uusitupa, M, et al. (2014) Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr 99, 7985.
67. Robinson, LE & Mazurak, VC (2013) n-3 Polyunsaturated fatty acids: relationship to inflammation in healthy adults and adults exhibiting features of metabolic syndrome. Lipids 48, 319332.
68. Harris, WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, 1645S1654S.
69. Sacks, FM, Stone, PH, Gibson, CM, et al. (1995) Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 25, 14921498.
70. Jones, PH, Davidson, MH, Stein, EA, et al. (2003) Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 92, 152160.
71. El Kadi, SW, Suryawan, A, Gazzaneo, MC, et al. (2012) Anabolic signaling and protein deposition are enhanced by intermittent compared with continuous feeding in skeletal muscle of neonates. Am J Physiol Endocrinol Metab 302, E674E686.
72. Fujita, S, Glynn, EL, Timmerman, KL, et al. (2009) Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. Diabetologia 52, 18891898.
73. Murphy, RA, Yeung, E, Mazurak, VC, et al. (2011) Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer 105, 14691473.
74. Esteghamati, A, Khalilzadeh, O, Anvari, M, et al. (2008) Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 39, 803808.
75. Vazquez, LA, Rodriguez, A, Salvador, J, et al. (2014) Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage. BMC Cardiovasc Disord 14, 153.

Keywords

Type Description Title
WORD
Supplementary materials

Clark supplementary material
Table S1-S5

 Word (30 KB)
30 KB

Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial

  • Louise F. Clark (a1) (a2), M. C. Thivierge (a1), Claire A. Kidd (a1), Susan C. McGeoch (a2), Prakash Abraham (a2), Donald W. M. Pearson (a2), Graham W. Horgan (a3), Grietje Holtrop (a3), Frank Thies (a1) and Gerald E. Lobley (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed